These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Ceftazidime in pediatric infections unsuccessfully treated with other antibiotics: an evaluation of its efficacy and tolerability in compromised host.
    Author: Boner AL, Castellani C, Fostini R, Padovani E.
    Journal: Int J Clin Pharmacol Ther Toxicol; 1986 Jun; 24(6):333-6. PubMed ID: 2942496.
    Abstract:
    Ceftazidime (C) is a cephalosporine active against Gram-positive and especially negative bacteria. The aim of the study was to evaluate efficacy and tolerance of C in the treatment of children suffering from infections previously treated unsuccessfully with different antibiotics. We examined 20 children, administering a dosage of C 30 to 100 mg/kg intravenously or intramuscularly for a mean treatment duration of 8.6 days. A favorable response was observed in all the children: of the 20 patients 13 were cured and 7 improved. A transient elevation of liver enzymes was noted in three children. The study confirms the efficacy of C in the treatment of severe infections. Since 9 of the 20 patients were neonates, we suggest the possible role of C in the newborns' infections.
    [Abstract] [Full Text] [Related] [New Search]